Search - tctmd.com

Displaying 1 - 20 of 94

Sort: Relevancy | Date

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Daily News

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

Todd Neale

November 01, 2019

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

Presentation TCT 2019

Indonesia Presents: Handling LAA Closure Device Implantation in Small LAA With Protruding Pectinate Muscles

Presenter: Teguh Santoso

September 28, 2019

Presentation TCT 2019

ICE Guidance as the Primary Strategy for LAA Closure: Technique and Data

Presenter: Mohamad Alkhouli

September 27, 2019

Presentation TCT 2019

Utility of CT for Pre-Procedural Planning and Device Selection

Presenter: Michael Rinaldi

September 27, 2019

Presentation TCT 2019

Case-Based Device Selection: Matching the Device With the Anatomy

Presenter: Reda Ibrahim

September 27, 2019

Presentation TCT 2019

Keynote Lecture: The Spectrum of LAA Closure Technology — Current and Emerging Devices

Presenter: Horst Sievert

September 27, 2019

Presentation TCT 2019

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Presenter: George Hanzel

September 27, 2019

Presentation TCT 2019

Optimal Timing for Surveillance Imaging After LAAC

Presenter: Saibal Kar

September 27, 2019

Presentation TCT 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presenter: Kishore Harjai

September 27, 2019

Presentation TCT 2019

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Presenter: Simon Cheung-chi Lam

September 27, 2019

Presentation TCT 2019

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

Presenter: Fabian Nietlispach

September 26, 2019

Presentation TCT 2019

LAA Closure in Patients With Prior Intracranial Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

September 26, 2019

Presentation TCT 2019

Clinical Rationale for LAA Closure After AF Ablation

Presenter: DJ Lakkireddy

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

LAA Closure in the United States: Update From the NCDR LAAO Registry

Presenter: Matthew Price

September 26, 2019

Presentation TCT 2019

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Presenter: James Hermiller

September 26, 2019

Advertisement

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Indonesia Presents: Handling LAA Closure Device Implantation in Small LAA With Protruding Pectinate Muscles

ICE Guidance as the Primary Strategy for LAA Closure: Technique and Data

Utility of CT for Pre-Procedural Planning and Device Selection

Case-Based Device Selection: Matching the Device With the Anatomy

Keynote Lecture: The Spectrum of LAA Closure Technology — Current and Emerging Devices

Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How?

Optimal Timing for Surveillance Imaging After LAAC

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status

TAVR Followed by LAA Closure: Implications for Bleeding, Stroke, and HALT

LAA Closure in Patients With Prior Intracranial Hemorrhage

Clinical Rationale for LAA Closure After AF Ablation

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

LAA Closure in the United States: Update From the NCDR LAAO Registry

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content